Biography and education
Brian Alas, MSN-Ed, BSN, RN, is a Simulation Laboratory Director and Clinical Assistant Professor at Texas State University’s St. David School of Nursing. He brings extensive experience in simulation-based education, clinical instruction, and academic program support across undergraduate and graduate nursing programs. In his role, he oversees simulation operations, curriculum integration, standardized patient programming, faculty development, and the implementation of evidence-based simulation practices aligned with AACN Essentials and Next Generation NCLEX standards.
Brian earned an Associate of Science Degree in Nursing (ADN) from Glendale Community College, followed by a Bachelor of Science in Nursing (BSN) and a Master of Science in Nursing Education (MSN-Ed) at Chamberlain University. He maintains active RN licensure in Texas and California and has a professional background that includes clinical practice, nursing education, and leadership in simulation program development. His educational pathway informs his student-centered teaching philosophy and his commitment to accessible, high-quality nursing education across diverse learning environments.
Brian earned an Associate of Science Degree in Nursing (ADN) from Glendale Community College, followed by a Bachelor of Science in Nursing (BSN) and a Master of Science in Nursing Education (MSN-Ed) at Chamberlain University. He maintains active RN licensure in Texas and California and has a professional background that includes clinical practice, nursing education, and leadership in simulation program development. His educational pathway informs his student-centered teaching philosophy and his commitment to accessible, high-quality nursing education across diverse learning environments.
Teaching Interests
Research Interests
Featured scholarly/creative works
- Ruane, P., & Alas, B. S. (2010). A 48-week pilot study switching suppressed patients to darunavir/ritonavir and etravirine from enfuvirtide, protease inhibitor(s), and non-nucleoside reverse transcriptase inhibitor(s). AIDS Research and Human Retroviruses, 26(11), 1215–1219. https://doi.org/https://doi.org/10.1089/aid.2009.0285
- Ruane, P., & Alas, B. S. (n.d.). A Phase IIIb Pilot Study Substituting Darunavir/ritonavir (DRV/r) and Etravirine (ETR) for Enfuvirtide (ENF) and Current PI in a Suppressive Regimen.
Featured service activities
- Volunteer
Texas State University Discovery Round Rock
- Volunteer
Workforce Solutions Rural Capital Area
- Member
Interprofessional Education
- Member
Interprofessional Education
- Chair
Simulation IPE Committee
- Member
Director's Council